致动脉粥样化血脂异常的临床试验
总计2834个结果
-
Pfizer终止
-
Amgen完全的患有高脂血症、血脂异常的受试者加拿大, 荷兰, 美国
-
Boryung Pharmaceutical Co., Ltd完全的
-
Hotel Dieu de France HospitalPfizer; Nouvelle Société Française d'Athérosclérose完全的
-
PfizerTIMI Study Group完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Fundación para el Fomento de la Investigación Sanitaria...完全的
-
AbbottRundo International Pharmaceutical Research & Development Co.,Ltd.完全的
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.完全的
-
Kowa Research Europe完全的
-
Misr University for Science and Technology主动,不招人
-
Merck Sharp & Dohme LLC终止
-
Erasmus Medical CenterDutch Heart Foundation完全的
-
NewAmsterdam PharmaUniversity of Pennsylvania招聘中
-
Organon and Co完全的
-
Centro Universitario de Ciencias de la Salud, MexicoCentro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco完全的
-
Fudan UniversityPeking University People's Hospital; Jiangsu Wanbang Medicine Marketing Co., Ltd.未知
-
University of UlsterThe Regional Centre for Studies in Food and Health (CREAS), Valparaíso, Chile完全的
-
AstraZeneca完全的
-
University of ParmaUniversita di Verona完全的肥胖 | INFLAMMATION | DYSLIPIDEMIA | CONSTIPATION意大利
-
Institute for Clinical Evaluative SciencesHeart and Stroke Foundation of Ontario; The Ontario Spor Support Unit; CorHealth Ontario; Knowledge... 和其他合作者招聘中